46.46.Z - Wholesale of pharmaceutical goods
33.20.Z - Installation of industrial machinery and equipment and outfit
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.99.Z - Other retail sale not in stores, stalls or markets
49.41.Z - Freight transport by road
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,2 | -0,2 | -0 | 88,1 |
Gross profit (loss) | -0,2 | -0,2 | 0,1 | 141,4 |
EBITDA | -0,1 | -0,2 | 0 | 113,2 |
Short time liabilities | 1 | 1,3 | 1,3 | 0,3 |
Other operating costs | 0 | 0 | 0 | 975,1 |
Equity capital | -0,7 | -1 | -0,9 | 11,4 |
Operating profit (EBIT) | -0,1 | -0,2 | 0 | 110 |
Assets | 0,5 | 0,6 | 0,7 | 15,8 |
Net profit (loss) | -0,2 | -0,2 | 0,1 | 141,4 |
Cash | 0,1 | 0 | 0 | 13,7 |
Net income from sale | 1,5 | 1,6 | 2 | 26 |
Liabilities and provisions for liabilities | 1,2 | 1,6 | 1,6 | -0,9 |
Working assets | 0,5 | 0,6 | 0,7 | 16,8 |
Other income costs | 0 | 0 | 0 | 451,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 23,3 | 21 | -9,8 | -30,8 |
Equity capital to total assets | -148,2 | -159 | -121,5 | 37,5 |
Gross profit margin | -11,9 | -13,1 | 4,3 | 17,4 |
EBITDA Margin | -8,6 | -9,9 | 1 | 10,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 250 | 302 | 241 | -61 |
Current financial liquidity indicator | 0.4946047365665436 | 0.4660884439945221 | 0.5426313281059265 | 0 |
Net dept to EBITDA | -1.4954943656921387 | -1.627152442932129 | 9.759371757507324 | 11,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane